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e-mail address: dr.khalid_alshehri@hotmail.com (K. Alshehri).Saad Waheeb a; Khalid Alshehri b,⇑AbstractPurpose: To review the incidence and risk factors for retinopathy of prematurity (ROP) King Faisal Specialist Hospital and King
Abdulaziz University Hospital in Jeddah, Saudi Arabia.
Material and methods: In this prospective cohort study, preterm infants who were admitted to a neonatal intensive care unit from
2012 to 2013 were evaluated for ROP. Inclusion criteria were, preterm infants with gestational age <32 weeks and/or birth weight
<1500 g. The risk factors that were assessed were intraventricular hemorrhage, patent ductus arteriosus (PDA), sepsis and hydro-
cephalus. The relative risk was used to measure the risk and logistic regression was used to adjust for confounding factors.
Statistical significance was indicated by p < 0.05.
Results: Thirty-one of 92 (33.7%) preterm infants had unilateral or bilateral ROP. The mean gestational age was 26.7 weeks (range,
24–29 weeks) and mean birth weight was 0.843 kg (range, 0.606–1.450 kg). There were 7 infants with stage 1 ROP, 10 infants with
stage 2, 14 infants with stage 3 and no cases of stage 4 or 5. Twelve (13%) infants had plus disease and received laser therapy
within 72 h of diagnosis. Statistically significant risk factors for ROP were PDA (p = 0.0005) and intraventricular hemorrhage
(p = 0.0005).
Conclusion: The incidence of ROP was 33.7% and risk factors were PDA and intraventricular hemorrhage. Laser therapy was very
effective for the treatment of plus disease and preventing progression of ROP. Clinicians should assess for potential risk factors
when monitoring premature infants.
Keywords: Retinopathy of prematurity (ROP), Plus disease, Threshold disease, Patent ductus arteriosus, Hydrocephalus, Intrav-
entricular hemorrhage
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Retinopathy of prematurity (ROP) is an abnormal growth
of retinal blood vessels that affect premature infants born
at or before 32 weeks and weighing 1500 g or less at birth.
ROP is usually bilateral and can lead to lifelong vision impair-
ment or blindness.1 The smaller an infant at birth, the greater
the likelihood of developing ROP. However, ROP can affectlarger and more mature infants. A study of ROP in Riyadh,
Saudi Arabia reported 56% of all premature births developed
ROP and 15% of these patients had stage 3 disease (severe
ROP).2 The mean gestational age (GA) of the ROP patients
was 30 weeks.2
In 2010, approximately 184,700 (uncertainty range,
169,600–214,500) preterm infants developed ROP (all stages)
worldwide. Twenty-thousand (range, 15,500–27,200) of thesee:
al.com
110 S. Waheeb, K. Alshehriinfants were severely visually impaired or blind. Additionally,
12,300 (8,300–18,400) preterm babies had mild to moderate
visual impairment. Sixty-five percent of patients who are visu-
ally impaired due to ROP, were born in middle-income
regions; 6.2% (4.3–8.9%) of all visually impaired infants with
ROP were born later than 32 weeks gestational age.3 In the
majority of cases, ROP regresses and improves with observa-
tion. However, a small percentage of infants develop severe
ROP that warrants laser treatment.
This prospective study evaluates the incidence of ROP
among highly vulnerable infants at 32 weeks (or younger)
gestational age and/or weighing less than 1500 g at birth.
Additionally, the risk factors for ROP that contributed to
ROP in this Saudi Arabian study population were evaluated.Table 1. Stages of the retinopathy of prematurity among premature infantsMaterial and methods
This prospective, cohort study evaluated the incidence of
ROP at the two hospitals and investigated the risk factors
for ROP. This study evaluated premature infants for ROP
who are admitted to the neonatal intensive care unit (NICU)
from September 2012 to October 2013 at King Faisal Special-
ist Hospital and King Abdulaziz University Hospital in Jeddah,
Saudi Arabia. Both facilities are tertiary care hospitals that
treat ROP cases referred from the entire country. The
research committee and biomedical ethics unit at King Abdu-
laziz University Hospital approved this study.
Inclusion criteria were, all infants who born 632 weeks
gestational age and/or birth weight 61500 g. Infants born
before 27 weeks were screened at 30–31 weeks postmen-
strual age (PMA). Infants born after 27 weeks or weighing
<1500 g were screened at 28–35 days postnatal age and
screened weekly or every 2 weeks.4 All infants were followed
up till they developed ROP or the retina was fully
vascularized.
All infants underwent indirect ophthalmoscopy after pupil
dilation with 1% topical mydriacyl with a 28 D lens, insertion
of a sterile lid speculum and scleral depression. Data were
collected on gestational age, birth weight, risk factors, stage
of ROP, zone of ROP, presence of plus disease, presence of
threshold disease and the type of treatment.
A group of infants who did not develop ROP was com-
pared to the group who developed ROP for the presence
and absence of risk factors (Table 4). The risk factors that
were assessed were, intraventricular hemorrhage, patent
ductus arteriosus (PDA), sepsis, and hydrocephalus. The
infants were assessed regularly until the retina was fully vas-
cularized. Treatment was performed within 72 h of diagnosis.
Infants who did not require laser treatment underwent rou-
tine vision screening, unless there was a specific concern.
The indications for treatment of severe ROP were: zone I,
any ROP with plus disease; zone I, stage 3 without plus dis-
ease; zone II, stage 3 with plus disease or; zone II, stage 2
with plus disease.5from two tertiary care hospitals in Saudi Arabia.
Stage of ROP Frequency (infants) Percentage (%)
1 7 22.5
2 10 32.3
3 14 45.2
Total 31 100
ROP = retinopathy of prematurityStatistical analysis
The data were collected for statistical analysis and entered
into the statistical package for social sciences (IBM Corp.,
Armonk, NY, USA). The relative risk was used to measure
the risk and logistic regression was used to adjust forconfounding factors. A p value less than 0.05 was considered
statistically significant.Results
Ninety-two premature infants were screened for ROP.
There were 31 (33.7%; 16 females and 15 males) infants diag-
nosed with ROP and 12 (13%) infants required laser treat-
ment. The mean gestational age was 26.7 weeks (range,
24 weeks to 29 weeks) and the mean birth weight was
0.843 kg (range, 0.606–1.450 kg).
There were fourteen (45.2%) infants with stage 3 ROP
which was the most common type of ROP in this study
(Table 1). The majority of cases (20 infants; 64.5%) were
found in zone 3 (Table 2). The fewest cases of ROP were in
zone 1 (2 cases; 6.5%) (Table 2). All cases needing treatment
received laser therapy within 72 h of diagnosis (Table 3).
After adjusting for confounding factors with logistic
regression, PDA and IVH had a significant effect on the occur-
rence of ROP. Hydrocephalus and sepsis were not significant
risk factors for ROP (Tables 4 and 5). Laser photocoagulation
was very effective in treating ROP. Out of all 31 patients with
ROP, 19 cases regressed with observation and 12 cases
regressed with laser therapy.Discussion
The incidence of ROP is rising in developing countries and
some premature infants with ROP are heavier than 1500 g. In
Western countries, extremely low-birth-weight infants
(61000 g) are surviving due to advances in neonatal care.
Hence there is an increase in the incidence of ROP in Western
countries also. The mean birth weights of infants from highly
developed countries ranged from 737 g to 763 g compared
with values ranging from 903 g to 1527 g in less developed
countries.6 Mean GAs of infants from highly developed coun-
tries ranged from 25.3 weeks to 25.6 weeks compared to
26.3–33.5 weeks in less developed countries.6
A 2003 study of infants at King Khalid University Hospital
in Riyadh, Saudi Arabia, reported an incidence rate of 41%
for infants weighing <1500 g and the mean gestational age
was 28 weeks and the mean birth weight was 1103 g.7 Simi-
larly, our study reported a relatively high incidence of ROP
at 33.7% for infants weighing <1500 g with mean gestational
age of 26.6 weeks and mean birth weight of 0.843 g. Another
study in Saudi Arabia reported an incidence of ROP was 56%
with a mean gestational age of 30 weeks for ROP patients
and 15% of the patients were in stage 3 disease (severe
ROP).2 However, in our study there were 13% of cases with
severe ROP that received laser treatment. A study from King
Fahad Medical City, Saudi Arabia evaluated premature
infants born at gestational age (GA) 32 weeks or younger
Table 2. Frequency of retinopathy of prematurity classified by zone.
Zone Frequency (infants) Percentage (%)
1 2 6.5
2 9 29
3 20 64.5
Total 31 100
Table 3. Plus disease among premature infants from two tertiary care
hospitals in Saudi Arabia.
Plus disease Frequency (infants) Percentage (%)
Yes 12 38.7
No 19 61.3
Total 31 100
Table 5. Risk factors for retinopathy of prematurity after adjustment for
confounding factors with logistic regression analysis.
p-
Value
Odds ratio O.
R
95% confidence
interval
PDA 0.003 6.201 1.850–20.780
IVH 0.000 29.968 5.515–162.828
Hydrocephalus 0.106 8.979 0.629–128.230
Sepsis 0.841 1.127 0.352–3.607
Intraventricular hemorrhage = IVH; patent ductus arteriosus = PDA
Incidence of RoP at two tertiary centers in Jeddah, Saudi Arabia 111or birth weight (BW) 1500 g or less from January 1, 2007, until
the end of December 2009.8 The study by Dr. Afaf reported
an ROP incidence of 30% in infants with mean GA of
27 weeks (range, 23–35 weeks) and mean birth weight of
907 g (range, 530–1730 g).8
The incidence of ROP in the current study is well within the
range reported for other countries in the region and else-
where. For example the incidence of ROP in Kuwait is
38.9%,9 in Taiwan is 37.8%,10 in Iran is 32%,11 in Egypt is
19.2%,12 in Jordan is 28.6%13 and in Bahrain is 20.4%.14 Most
of these countries are reporting an increased incidence of
ROP in infants weighing less than 1500 g.
In our study, the risk factors that were statistically signifi-
cantly associated to ROP were PDA and IVH. However, two
studies one from Turkey and the other from India, reported
a relationship between PDA and incidence of ROP in infants
younger than 32 weeks.15,16 Additionally, an Irish study
reported that in 68 infants with IVH, ROP was present in 33
infants (48.5%).17 Another study from Saudi Arabia used pre-
dictive logistic regression model and reported intraventricu-
lar hemorrhage was a risk factor for ROP (OR = 2.90).8
Laser therapy is extremely effective for treatment of type 1
threshold ROP, with a success rate of 91–95% except for
some zone 1 eyes.18 We found that 13% of ROP cases
required treatment. However, other studies have reported
ROP treatment rates of 6.6% in Jordan,13 15% in Saudi Ara-
bia,2 19% in Saudi Arabia,7 6% in Bahrain,14 and 7.8% in
Kuwait.9 In our study, the disease regressed in all infants
who received laser therapy. Based on our experience in the
current study, laser photocoagulation was very effective in
treating ROP. All our patients regressed either with observa-
tion or laser treatment and none progressed to stage 4 or 5
disease.Table 4. Risk factors for retinopathy of prematurity in the study group and a c
ROP group No ROP group
PDA Yes: 16
No:15
Yes: 9
No: 52
IVH Yes: 15
No: 16
Yes: 2
No: 59
Hydrocephalus Yes: 5
No: 26
Yes: 1
No: 60
Sepsis Yes: 18
No: 13
Yes: 32
No: 29
ROP = retinopathy of prematurityConclusions
The incidence of ROP was 33.7%. The significant risk fac-
tors for ROP were PDA and IVH. Twelve (13%) cases under-
went laser therapy which was very effective in preventing
progression of the disease. Therefore, clinicians should be
aware of the presence of these risk factors when monitoring
premature infants. Timely laser therapy can reduce the visual
morbidity associated with ROP.Conflict of interest
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